Puducherry Official Ousted After Systematic Failure to Halt Fake Medicine Trade

Regulatory Oversight Fails Amid Rise in Spurious Pharmaceuticals

The Puducherry administration has suspended Drugs Inspector E. Anandakirouchenane, citing a consistent failure to prevent the illicit production and distribution of counterfeit medications within the Union Territory. The disciplinary action follows a series of high-profile raids that exposed a thriving underground pharmaceutical network. An official order signed by Health Secretary Choudhary Mohammed Yasin on July 23 identifies a pattern of "systematic, prolonged, and continued negligence" by the officer, who had held authority over drug control since 2022.

Evidence of Procedural Lapses and Institutional Neglect

Authorities allege that Anandakirouchenane bypassed necessary field inspections and failed to compile data on unlicensed facilities. The administration characterized these lapses as either a "practice of deliberate omission" or severe "wilful neglect." Despite persistent reports regarding the growth of a black market for medicine, the Drugs Control department under his leadership failed to implement enforcement measures until outside agencies intervened. Key findings from the investigation include:

• Historical Failures: Reports of counterfeit drug operations emerged shortly after the inspector's 2022 designation, but no definitive action was taken against known violators.
• Proliferation of Illegal Sites: Multiple manufacturing hubs continued to function without licenses, avoiding detection despite official complaints.
• International Implications: Evidence suggests that counterfeit drugs produced in these units were exported illegally to foreign markets.

Previous Crackdowns and Enforcement History

The current suspension follows a string of significant police actions. Last year, law enforcement officials raided 13 separate locations, resulting in 26 arrests related to the manufacturing of fraudulent medicines. That investigation was eventually transferred to the Central Bureau of Investigation (CBI). More recently, two additional illegal factories were discovered just weeks ago, forcing the government’s hand in holding the regulatory leadership accountable for the regulatory vacuum that enabled these operations to survive.

Source: The Hindu — Cities